Siena Biotech Buys More Licenses to GeneGo's MetaCore

Jul 07, 2006

NEW YORK (GenomeWeb News) - GeneGo said today that Siena Biotech has expanded its collection of MetaCore licenses by an undisclosed amount.

Siena is using the MetaCore technology to integrate multiple data types including proteomics and chemogenomics information.

Financial terms were not disclosed.

Other customers have recently extended their licenses with GeneGo, such as NHLBI in June and Merck in January.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.